Onderneming Breathtec Biomedical Inc Deutsche Boerse AG
Aandelen
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 01-03-18 |
James Kinley
DFI | Director of Finance/CFO | 45 | 01-12-21 |
Chief Operating Officer | 41 | 01-03-21 | |
Ahmad Khalil
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 08-09-21 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 01-03-18 |
Mark Williams
BRD | Director/Board Member | 52 | 22-09-21 |
James Kinley
DFI | Director of Finance/CFO | 45 | 01-12-21 |
Raj Attariwala
BRD | Director/Board Member | 55 | 26-10-15 |
Howard Gutman
BRD | Director/Board Member | - | 28-02-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 21 840 722 | 21 665 319 ( 99,20 %) | 0 | 99,20 % |
Bedrijfsgegevens
Algernon Pharmaceuticals, Inc.
601 West Broadway Street Suite 400
V5Z 4C2, Vancouver
+604-398-4175
http://www.algernonpharmaceuticals.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,58% | 115 mld. | |
+12,41% | 107 mld. | |
-3,49% | 21,6 mld. | |
-12,38% | 22,31 mld. | |
-6,82% | 19,19 mld. | |
-3,35% | 18,23 mld. | |
-38,57% | 17,62 mld. | |
+7,51% | 14,26 mld. | |
+35,67% | 12,37 mld. |